Zobrazeno 1 - 10
of 619
pro vyhledávání: '"S. Thayumanavan"'
Exogenous Introduction of Initiator and Executioner Caspases Results in Different Apoptotic Outcomes
Publikováno v:
JACS Au, Vol 1, Iss 8, Pp 1240-1256 (2021)
Externí odkaz:
https://doaj.org/article/72d8e511927844128801c27706b55122
Autor:
Kingshuk Dutta, Ritam Das, Jing Ling, Rafael Mayoral Monibas, Ester Carballo-Jane, Ahmet Kekec, Danqing Dennis Feng, Songnian Lin, James Mu, Robert Saklatvala, S. Thayumanavan, Yingkai Liang
Publikováno v:
ACS Omega, Vol 5, Iss 28, Pp 17531-17542 (2020)
Externí odkaz:
https://doaj.org/article/e07bb7861fcc44ce9fd240665f45f633
Publikováno v:
Langmuir. 39:1793-1803
Autor:
Uyen Huynh, Peidong Wu, Jingyi Qiu, Theeraphop Prachyathipsakul, Khushboo Singh, D. Joseph Jerry, Jingjing Gao, S. Thayumanavan
Publikováno v:
Biomacromolecules. 24:849-857
Publikováno v:
Chemistry Central Journal, Vol 12, Iss 1, Pp 1-9 (2018)
Abstract A series of D–A dyads and D–A–D triads molecular systems based on triphenylamine and 9-ethyl-carbarzole as donor (D) and BODIPY as acceptor (A) has been designed and synthesized. The optoelectronic properties including optical, electro
Externí odkaz:
https://doaj.org/article/8a2f2272dd5546d49e97ed968c1638c1
Autor:
Ranit Dutta, Sparsh Makhaik, Peiyao Zhao, Kristalle G. Cruz, Kwang-Won Park, Hongxu Liu, Trisha L. Andrew, Jeanne A. Hardy, S. Thayumanavan
Publikováno v:
Analytical Chemistry. 94:12699-12705
Reporting the activity of a specific viral protease remains an acute need for rapid point-of-care detection strategies that can distinguish active infection from a resolved infection. In this work, we present a simple colorimetric approach for report
Multisite Labeling of Proteins Using the Ligand-Directed Reactivity of Triggerable Michael Acceptors
Autor:
Myrat Kurbanov, Zachary J. Kirsch, Jithu Krishna, Ranit Dutta, Richard W. Vachet, S. Thayumanavan
Publikováno v:
Bioconjugate Chemistry.
Publikováno v:
Bioconjugate Chemistry. 33:1996-2007
Recent success of mRNA-based COVID-19 vaccines have bolstered the strength of nucleic acids as a therapeutic platform. The number of new clinical trial candidates is skyrocketing with the potential to address many unmet clinical needs. Despite advanc
Autor:
Khushboo Singh, Mine Canakci, Pintu Kanjilal, Natalie Williams, Sudarvili Shanthalingam, Barbara A. Osborne, S. Thayumanavan
Publikováno v:
Bioconjug Chem
Targeted delivery of chemotherapeutic drugs can improve their therapeutic efficiency by localizing their toxic effects at the diseased site. This is often achieved either by direct conjugation of drugs to antibodies targeting overexpressed receptors
Publikováno v:
Polymer International. 71:562-568